RT Journal Article
SR Electronic
T1 On the protective role of the blood vessels in glaucomatous damage: a transversal study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.17.21253785
DO 10.1101/2021.03.17.21253785
A1 Cánovas-Serrano, Yaiza
A1 Vallés-San-Leandro, Lorenzo
A1 Rodríguez-Izquierdo, Miguel Ángel
A1 Lajara-Blesa, Jerónimo
A1 López-Serrano, Rafael
YR 2021
UL http://medrxiv.org/content/early/2021/03/17/2021.03.17.21253785.abstract
AB Purpose To corroborate whether vessels on the surface of the optic nerve head can provide protection against the loss of underlying axons in subjects with manifest glaucoma.Methods In this pilot study, thirty-six glaucomatous eyes with a perimetric defect in the Bjerrum area were included. The retinal nerve fiber layer (RNFL) thickness was measured in each of the sectors of the clock-hour map obtained by Cirrus HD-OCT considering the presence or absence of blood vessels. These sectors were related with their corresponding areas of the retina examined in the visual field using a mathematical model of the retina introduced by Jansonius, in order to determine the values of threshold sensitivity in those areas in the presence or absence of vessels.Results We corroborated the protective role of the blood vessel for peripapillary RNFL thickness of clock-hour 12 despite obtaining a p-value (p = 0.023; w = 228.5) close to the acceptance zone (p ≥ 0.05). The mean ± standard deviation with vessel and without vessel were 70.95 ± 24.35 and 88.46 ± 23.96, respectively. No differences were found between the mean values of threshold sensitivity to the presence or absence of blood vessels in each of the sectors considered.Conclusions Our findings do not allow us to affirm that there is an association between the presence of a vessel and protection against glaucomatous damage in subjects with an advanced manifestation of the disease. In the future, more extensive studies are needed to study this relationship in subjects with early glaucoma.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was received for this researchAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of the Catholic University of Murcia (CE041809). The present investigation was conducted according to the tenets of the Declaration of Helsinki and current regulations to protect the confidentiality of data. The research is based entirely on the clinical routine and is obtained from the patients medical record system. Therefore, no informed consent is required.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.IOPIntraocular pressureONHOptic nerve headPOAGPrimary open angle glaucomaOCTOptical coherence tomographySDSpectral domainRNFLRetinal nerve fiber layerNFLNerve fiber layer.